A NOVEL HUMAN G-PROTEIN COUPLED RECIPTOR HGPRBMY11 EXPRESSED HIGHLY IN HEART AND VARIANTS THEREOF

Details for Australian Patent Application No. 2001297769 (hide)

Owner BRISTOL-MYERS SQUIBB COMPANY

Inventors FEDER, John; NELSON, Thomas, C.; RAMANATHAN, Chandra; CACACE, Angela, M.; BARBER, Lauren, E.

Pub. Number AU-A-2001297769

PCT Number PCT/US01/44019

PCT Pub. Number WO2002/086123

Priority 60/305,818 16.07.01 US; 60/249,613 17.11.00 US; 60/257,611 21.12.00 US

Filing date 16 November 2001

Wipo publication date 5 November 2002

International Classifications

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C07K 014/705 Peptides having more than 20 amino acids

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 031/713 - Double-stranded nucleic acids or oligonucleotides

A61K 038/17 Medicinal preparations containing peptides - from animals

G01N 033/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 033/566 Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 60/305,818 16.07.01 US; 60/249,613 17.11.00 US; 60/257,611 21.12.00 US

17 April 2003 Application Open to Public Inspection

  Published as AU-A-2001297769

28 June 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001297770-Use of CLyA hemolysin for excretion of fusion proteins

2001297768-MODULATION OF GENE EXPRESSION IN MOUSE GENETIC MODELS OF ATHEROSCLEROSIS